fbpx
September 23, 2022

Trans-auricular VNS ‘Very Clever’ for Parkinson’s Disease Trans-auricular VNS ‘Very Clever’ for Parkinson’s Disease

Trans-auricular vagus nerve stimulation (taVNS) is feasible, well-tolerated, and may improve motor function in patients with Parkinson’s Disease (PD), new research suggests. The field of noninvasive […]
September 23, 2022

Experts Issue Health Warning About Giving Melatonin to Kids Experts Issue Health Warning About Giving Melatonin to Kids

The American Academy of Sleep Medicine (AASM) has issued a health advisory encouraging parents to talk to a healthcare professional before giving melatonin or any supplement […]
September 23, 2022

Resistance Training Tied to Improvements in Parkinson’s Symptoms Resistance Training Tied to Improvements in Parkinson’s Symptoms

Resistance training (RT) can help improve several symptoms of Parkinson’s Disease (PD) — but is not superior to other physical activities, new research suggests. A meta-analysis, […]
September 23, 2022

First Known Opiate Biomarker Shows Fentanyl’s Effect on Brain First Known Opiate Biomarker Shows Fentanyl’s Effect on Brain

Fentanyl depresses breathing about 4 minutes before symptoms of distress are evident at a dose that is 1700 times lower than that needed for sedation, new […]
September 23, 2022

Sport Climbing Tied to Improved Posture in Parkinson’s Disease Sport Climbing Tied to Improved Posture in Parkinson’s Disease

Sport climbing can help improve posture in patients with Parkinson’s Disease (PD), including older patients, new research suggests. In a randomized controlled study, those who participated […]
September 21, 2022

Serious Infections Linked to Early Alzheimer’s, Parkinson’s Disease Serious Infections Linked to Early Alzheimer’s, Parkinson’s Disease

Patients in early- and mid-life who contract with infections that require hospitalization appear to be at increased risk for neurodegenerative diseases, including Alzheimer’s disease (AD) and […]
September 20, 2022

Vutrisiran Receives EU Approval for hAATR Amyloidosis Vutrisiran Receives EU Approval for hAATR Amyloidosis

Vutrisiran (Amvuttra) has been approved by the European Commission (EC) for treatment of hereditary transthyretin-mediated (hATTR) amyloidosis in adults with stage 1 or 2 polyneuropathy, the […]
September 19, 2022

An EEG Marker of Balance and Cognition in Parkinson’s An EEG Marker of Balance and Cognition in Parkinson’s

The study covered in this summary was published on BioRxiv.org as a preprint and has not yet been peer reviewed. Key Takeaway Why This Matters Study […]
September 19, 2022

A History of Head Trauma May Predict Parkinson Progression A History of Head Trauma May Predict Parkinson Progression

A history of head trauma may predict a more rapid decline in patients with Parkinson’s disease (PD), new research suggests. In a longitudinal online study, among […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0